Welcome. If you're a registered user, please log-in. If not, please sign-up.
Change Language
Russian Pharmaceutical Forum - the meeting place for the TOP industry players

DON'T MISS THE RUSSIAN PHARMACEUTICAL FORUM IN 2014

Topics, formats and features to give you the best possible experience

 

BOARD-LEVEL VIEW ON HOW TO MAKE RUSSIA COMPETITIVE IN ATTRACTING INVESTMENTS

Join top international executives and well-known leaders, who will share their views on what Russia can offer in board-level discussions on long-term revenue generation prospects. The panel will feature Patrick Aghanian, Head of Eurasia Region, Sanofi Russia, William Charnetski, Vice-President, Corporate Affairs International, AstraZeneca, Anders Tullgren, Senior Vice-President , Europe, BMS


REGULATORY REVIEW 

 

This session, featuring representatives of top regulators, will discuss the further development of regulatory mechanisms for the pharmaceutical market, consider key reasons and necessary steps for creating a healthy competitive environment in the sector, and offer views on how to perfect and enforce price regulation policies


WHAT IS NEXT FOR THE RUSSIAN PHARMA MARKET?

 

Share your ideas with the most successful MDs and CEOs of the leading pharmaceutical companies working in Russia, who will come together to discuss the most important  commercial and market challenges, as well as assess the healthcare system’s key pressure points



HEALTH CARE FUNDING: What does the future hold for reimbursement and pricing regulation?

The panel, featuring regulators, producers, insurance companies, academics and strategic consultants, will focus on the recent suggestions and models for changes in healthcare funding and reimbursement


DISTRIBUTION STRATEGY DEBATE – Models to enable collaboration and efficiency

 

Pharmaceutical companies are under increasing pressure to preserve their profit margins. Will manufacturers and distributors continue to rely on each other’s actions and resources to minimise distribution risks? What are the current dynamics between manufacturers, distributors and retail pharmacies, in terms of sales volumes, price setting and product assortment strategies? Looking at the key niche distributors, regional players and short-lines


GROWTH OF LOCAL PRODUCTION AND DEVELOPMENT OF LOCAL PRODUCERS

Analysing the strategies of leading national players: What are the most promising business models? With state programmes focusing on supporting local innovation and with the growing costs for development of new generics / biosimilars, what does the future hold for those manufacturers with few innovative products in their portfolio?


NAVIGATING RETAIL STRATEGIES IN A CHANGING ENVIRONMENT

The session will feature executives from federal and regional chains, as well as representatives of pharmaceutical companies. They will discuss growing entrance barriers (the entrance ticket price) and the commercial viability of working with bigger retail chains


SPOTLIGHT ON ASIA

Discovering strategies for fostering growth and establishing optimal partnership models


PATIENT ADVOCACY

Building relationships between patient groups and the pharmaceutical industry



Speakers

Speakers

Vasily Ignatiev CEO R-Pharm

Motupalli Ramana Executive Vice President, Emerging Markets Dr Reddy's Laboratories

Dmitriy Efimov Vice President for Russia, CIS and Baltic States STADA AG

Dmitry Morozov Chairman of the Board of Directors BIOCAD

Larisa Popovich Director, Health Economics Institute The Higher School of Economics

Andrey Gusev General Director Pharmacies “A5”


Follow Us - #RPF2014

Related Events

Adam Smith Conferences' 6th annual

Ukrainian Pharmaceutical Forum

October 2014
Kyiv, Ukraine, Venue TBC


Adam Smith Conferences'

Drug Manufacturing in Russia and CIS

February 2015
Moscow, Russia, Venue TBC